The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Diabetic Nephropathy and Extracellular Matrix
Open accessAbstract
Diabetic nephropathy (DN) is a serious complication in diabetes. Major typical morphological changes are the result of changes in the extracellular matrix (ECM). Thus, basement membranes are thickened and the glomerular mesangial matrix and the tubulointerstitial space are expanded, due to increased amounts of ECM. One important ECM component, the proteoglycans (PGs), shows a more complex pattern of changes in DN. PGs in basement membranes are decreased but increased in the mesangium and the tubulointerstitial space. The amounts and structures of heparan sulfate chains are changed, and such changes affect levels of growth factors regulating cell proliferation and ECM synthesis, with cell attachment affecting endothelial cells and podocytes. Enzymes modulating heparan sulfate structures, such as heparanase and sulfatases, are implicated in DN. Other enzyme classes also modulate ECM proteins and PGs, such as matrix metalloproteinases (MMPs) and serine proteases, such as plasminogen activator, as well as their corresponding inhibitors. The levels of these enzymes and inhibitors are changed in plasma and in the kidneys in DN. Several growth factors, signaling pathways, and hyperglycemia per se affect ECM synthesis and turnover in DN. Whether ECM components can be used as markers for early kidney changes is an important research topic, whereas at present, the clinical use remains to be established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wijnhoven, T. J. M., Lensen, J. F. M., Wismans, R. G., Lamrani, M., Monnens, L. A. H., Wevers, R. A., Rops, A. L. W. M. M., van der Vlag, J., Berden, J. H. M., van den Heuvel, L. P. W. J., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070692 · Cited by 49
Retracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394 · cited 1×
“Therefore, either angiotensinconverting enzyme (ACE) inhibitors (Lewis et al. 1993) or angiotensin II receptor blockers (Lewis et al. 1993; Brenner et al. 2001) are the cornerstones of renoprotective therapy once increased albuminuria has developed.”
BackgroundThe Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset Diabetes
Mogensen, C. E. (1984) · New England Journal of Medicine · doi:10.1056/nejm198402093100605 · Cited by 1,908
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.12.005 · Cited by 1,788
Pathologic Classification of Diabetic Nephropathy
Tervaert, T. W. C., Mooyaart, A. L., Amann, K., Cohen, A. H., Cook, H. T., Drachenberg, C. B., Ferrario, F., Fogo, A. B., Haas, M., de Heer, E., et al. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010010 · Cited by 1,690
Predicting Diabetic Nephropathy in Insulin-Dependent Patients
Mogensen, C. E., & Christensen, C. K. (1984) · New England Journal of Medicine · doi:10.1056/nejm198407123110204 · Cited by 1,569
Order Out of Chaos: Assembly of Ligand Binding Sites in Heparan Sulfate
Esko, J. D., & Selleck, S. B. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135458 · Cited by 1,495
Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
Navarro-González, J. F., Mora-Fernández, C., de Fuentes, M. M., & García-Pérez, J. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.51 · Cited by 1,072
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions
Ritz, E., Rychlík, I., Locatelli, F., & Halimi, S. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70035-1 · Cited by 806
A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092150 · Cited by 775
Rehm, M., Bruegger, D., Christ, F., Conzen, P., Thiel, M., Jacob, M., Chappell, D., Stoeckelhuber, M., Welsch, U., Reichart, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.684852 · Cited by 669
Filmus, J., Capurro, M., & Rast, J. (2008) · Genome Biology · doi:10.1186/gb-2008-9-5-224 · Cited by 556
Prevention of diabetic renal disease with special reference to microalbuminuria
Mogensen, C. E., Keane, W. F., Bennett, P. H., Striker, G. E., Jerums, G., Parving, H.-H., Passa, P., Steffes, M. W., & Viberti, G. C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91747-0 · Cited by 543
Basement membrane proteoglycans: from cellar to ceiling
Iozzo, R. V. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1702 · Cited by 521
Pathways to nephron loss starting from glomerular diseases—Insights from animal models
Kriz, W., & Lehir, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.67097.x · Cited by 468
Structural-functional correlations in renal disease
Schainuck, L. I., Striker, G. E., Cutler, R. E., & Benditt, E. P. (1970) · Human Pathology · doi:10.1016/s0046-8177(70)80061-2 · Cited by 462
Declining Incidence of Nephropathy in Insulin-Dependent Diabetes Mellitus
Bojestig, M., Arnqvist, H. J., Hermansson, G., Karlberg, B. E., & Ludvigsson, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401063300103 · Cited by 453
Nonalbuminuric Renal Insufficiency in Type 2 Diabetes
MacIsaac, R. J., Tsalamandris, C., Panagiotopoulos, S., Smith, T. J., McNeil, K. J., & Jerums, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.195 · Cited by 411
Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 376
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Manon‐Jensen, T., Itoh, Y., & Couchman, J. R. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07798.x · Cited by 337
The glomerular basement membrane
Miner, J. H. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.031 · Cited by 337
NANGAKU, M. (2004) · Internal Medicine · doi:10.2169/internalmedicine.43.9 · Cited by 336
Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability
Salmon, A. H., & Satchell, S. C. (2012) · The Journal of Pathology · doi:10.1002/path.3964 · Cited by 315
Molitch, M. E., Steffes, M., Sun, W., Rutledge, B., Cleary, P., de Boer, I. H., Zinman, B., Lachin, J., & for the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1098 · Cited by 306
Syndecans in wound healing, inflammation and vascular biology
Alexopoulou, A. N., Multhaupt, H. A. B., & Couchman, J. R. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.10.014 · Cited by 294
Matrix metalloproteinases in kidney homeostasis and diseases
Tan, R. J., & Liu, Y. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00037.2012 · Cited by 265
Syndecans as receptors and organizers of the extracellular matrix
Xian, X., Gopal, S., & Couchman, J. R. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0829-3 · Cited by 264
A monoclonal antibody against GBM heparan sulfate induces an acute selective proteinuria in rats
van den Born, J., van den Heuvel, L. P. W. J., Bakker, M. A. H., Veerkamp, J. H., Assmann, K. J. M., & Berden, J. H. M. (1992) · Kidney International · doi:10.1038/ki.1992.15 · Cited by 233
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 226
The Consequences of Tubulo-Interstitial Changes for Renal Function in Glomerulopathies
Bohle, A., Mackensen-Haen, S., von Gise, H., Grund, K.-E., Wehrmann, M., Batz, C., Bogenschütz, O., Schmitt, H., Nagy, J., Müller, C., et al. (1990) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)81021-6 · Cited by 204
Glomerular heparan sulfate alterations: Mechanisms and relevance for proteinuria
Raats, C. J. I., Van Den Born, J., & Berden, J. H. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00858.x · Cited by 200
Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
Gil, N., Goldberg, R., Neuman, T., Garsen, M., Zcharia, E., Rubinstein, A. M., van Kuppevelt, T., Meirovitz, A., Pisano, C., Li, J.-P., et al. (2012) · Diabetes · doi:10.2337/db11-1024 · Cited by 190
Harvey, S. J., Jarad, G., Cunningham, J., Rops, A. L., van der Vlag, J., Berden, J. H., Moeller, M. J., Holzman, L. B., Burgess, R. W., & Miner, J. H. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061116 · Cited by 186
Prevalence of Arterial Hypertension in Diabetic Patients Before and After the JNC-V
Tarnow, L., Rossing, P., Gall, M.-A., Nielsen, F. S., & Parving, H.-H. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1247 · Cited by 184
Burrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 170
Syndecan-1 Shedding Is Enhanced by LasA, a Secreted Virulence Factor of Pseudomonas aeruginosa
Park, P. W., Pier, G. B., Preston, M. J., Goldberger, O., Fitzgerald, M. L., & Bernfield, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.5.3057 · Cited by 160
Fine-tuning of cell signaling by glypicans
Fico, A., Maina, F., & Rosana, D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7471-6 · Cited by 153
Schaefer, L., Raslik, I., Gröne, H., Schönherr, E., Mačáková, K., Ugorcakova, J., Budny, S., Schaefer, R. M., & Kresse, H. (2001) · The FASEB Journal · doi:10.1096/fj.00-0493fje · Cited by 150
Evidence that TGF-β should be a therapeutic target in diabetic nephropathy
Border, W. A., & Noble, N. A. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00127.x · Cited by 146
Bangstad, H. ‐., Dahl‐Jørgensen, K., Hanssen, K. F., Østerby, R., Berg, K. J., & Hartmann, A. (1994) · Diabetologia · doi:10.1007/s001250050136 · Cited by 145
The glomerular endothelial cell coat is essential for glomerular filtration
Fridén, V., Oveland, E., Tenstad, O., Ebefors, K., Nystrom, J. C., Nilsson, U. A., & Haraldsson, B. S. (2011) · Kidney International · doi:10.1038/ki.2011.58 · Cited by 140
Increased expression of heparanase in overt diabetic nephropathy
van den Hoven, M. J., Rops, A. L. W. M. M., Bakker, M. A. H., Aten, J., Rutjes, N. W. P., Roestenberg, P., Goldschmeding, R., Zcharia, E., Vlodavsky, I., van der Vlag, J., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001985 · Cited by 133
Lane, P. H., Steffes, M. W., & Mauer, S. M. (1992) · Diabetes · doi:10.2337/diab.41.5.581 · Cited by 125
Nguyen, T. Q., Tarnow, L., Jorsal, A., Oliver, N., Roestenberg, P., Ito, Y., Parving, H., Rossing, P. R., van Nieuwenhoven, F. A., & Goldschmeding, R. (2008) · Diabetes Care · doi:10.2337/dc07-2469 · Cited by 119
Shimizu, F., Sano, Y., Haruki, H., & Kanda, T. (2011) · Diabetologia · doi:10.1007/s00125-011-2107-7 · Cited by 119
Matrix Metalloproteinase-2 Dysregulation in Type 1 Diabetes
Thrailkill, K. M., Bunn, R. C., Moreau, C. S., Cockrell, G. E., Simpson, P. M., Coleman, H. N., Frindik, J. P., Kemp, S. F., & Fowlkes, J. L. (2007) · Diabetes Care · doi:10.2337/dc07-0162 · Cited by 116
Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease
Stokes, M. B., Holler, S., Cui, Y., Hudkins, K. L., Eitner, F., Fogo, A. B., & Alpers, C. E. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00868.x · Cited by 111
Potential New Therapeutic Agents for Diabetic Kidney Disease
Turgut, F. H., & Bolton, W. K. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.021 · Cited by 95
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus
Myrup, B., Hansen, P. M., Kofoed‐Enevoldsen, A., Feldt‐Rasmussen, B., Deckert, T., Jensen, T., Jespersen, J., & Kluft, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90403-4 · Cited by 91
Tinkering with heparan sulfate sulfation to steer development
Gorsi, B., & Stringer, S. E. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.02.006 · Cited by 89
Haraldsson, B. S., & Nystrom, J. C. (2012) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283522e7a · Cited by 87
Abnormal Glomerular Permeability Characteristics in Diabetic Nephropathy
Lewis, E. J., & Xu, X. (2008) · Diabetes Care · doi:10.2337/dc08-s251 · Cited by 82
Steer, D. L., Shah, M. M., Bush, K. T., Stuart, R. O., Sampogna, R. V., Meyer, T. N., Schwesinger, C., Bai, X., Esko, J. D., & Nigám, S. K. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.04.029 · Cited by 74
Svennevig, K., Hoel, T. N., Thiara, A., Kolset, S. O., Castelheim, A., Mollnes, T., Brosstad, F. R., Fosse, E. T., & Svennevig, J. L. (2008) · Perfusion · doi:10.1177/0267659108098215 · Cited by 71
Self-citationWT1-Dependent Sulfatase Expression Maintains the Normal Glomerular Filtration Barrier
Schumacher, V., Schlötzer-Schrehardt, U. M., Karumanchi, S. A., Shi, X., Zaia, J., Jeruschke, S., Zhang, D., Pavenstädt, H., Drenckhan, A., Amann, K., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080860 · Cited by 71
Mason, R. M. (2009) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0038-6 · Cited by 69
Conde‐Knape, K. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.236 · Cited by 66
Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy
Wijnhoven, T. J. M., van den Hoven, M. J. W., Ding, H. G., Kuppevelt, T. H. V., van der Vlag, J., Berden, J. H. M., Prinz, R. A., Lewis, E. J., Schwartz, M. M., & Xu, X. (2007) · Diabetologia · doi:10.1007/s00125-007-0879-6 · Cited by 61
Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications
Lieberthal, W., & Levine, J. S. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00015.2012 · Cited by 61
Revisiting the glomerular charge barrier in the molecular era
Harvey, S. J., & Miner, J. H. (2008) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e32830464de · Cited by 58
Renal Accumulation of Biglycan and Lipid Retention Accelerates Diabetic Nephropathy
Thompson, J. C., Wilson, P. G., Brandewie, K. L., Taneja, D., Schaefer, L., Mitchell, B. L., & Tannock, L. R. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.05.016 · Cited by 52
van den Born, J., Pisa, B. J. M., Bakker, M. A. H., Celie, J. W. A. M., Straatman, C., Thomas, S., Viberti, G. C., Kjellén, L., & Berden, J. H. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601552200 · Cited by 46
Yard, B. A., Kahlert, S., Engelleiter, R., Resch, S., Waldherr, R., Groffen, A. J. A., van den Heuvel, L. P., Born, J. V. D. W., Berden, J. H. M., Kröger, S., et al. (2001) · Nephron Experimental Nephrology · doi:10.1159/000052614 · Cited by 44
Insulin increases shedding of syndecan-1 in the serum of patients with type 2 diabetes mellitus
Wang, J., Guan, J., Shen, J., Zhou, L., Zhang, Y., Si, Y., Yang, L., Jian, X., & Sheng, Y. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.08.002 · Cited by 43
Wijnhoven, T. J. M., Lensen, J. F. M., Rops, A. L. W. M. M., van der Vlag, J., Kolset, S. O., Bangstad, H., Pfeffer, P. F., van den Hoven, M. J. W., Berden, J. H. M., van den Heuvel, L. P. W. J., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.05.003 · Cited by 41
Self-citationKishi, S., Abe, H., Akiyama, H., Tominaga, T., Murakami, T., Mima, A., Nagai, K., Kishi, F., Matsuura, M., Matsubara, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.244541 · Cited by 38
Hill, R., & WILLIAMS, P. E. (2002) · Journal of Anatomy · doi:10.1046/j.1469-7580.2002.00083.x · Cited by 31
Contribution of Proteoglycans Towards the Integrated Functions of Renal Glomerular Capillaries
Kanwar, Y. S., Danesh, F. R., & Chugh, S. S. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070356 · Cited by 30
Insulin-dependent Diabetes Mellitus in Mice Does Not Alter Liver Heparan Sulfate
Bishop, J. R., Foley, E. M., Lawrence, R., & Esko, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112391 · Cited by 20
Basement membrane proteoglycans and development
Couchman, J., Abrahamson, D. R., & McCarthy, K. J. (1993) · Kidney International · doi:10.1038/ki.1993.14 · Cited by 20
Nakajima, T., Hasegawa, G., Kamiuchi, K., Fukui, M., Yamasaki, M., Tominaga, M., Asano, M., Hosoda, H., Yoshikawa, T., & Nakamura, N. (2006) · Redox Report · doi:10.1179/135100006x116736 · Cited by 14
NG2 proteoglycan increases mesangial cell proliferation and extracellular matrix production
Xiong, J., Wang, Y., Zhu, Z., Liu, J., Wang, Y., Zhang, C., Hammes, H., Lang, F. J. W., & Feng, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.113 · Cited by 14
Holmquist, P., & Torffvit, O. (2008) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590802502111 · Cited by 4
Cited by
Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney
Nastase, M. V., Zeng-Brouwers, J., Beckmann, J., Tredup, C., Christen, U., Radeke, H. H., Wygrecka, M., & Schaefer, L. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.002 · Cited by 60
Song, G., Han, P., Sun, H., Shao, M., Yu, X., Wang, W., Wang, D., Yi, W., Ge, N., Li, S., et al. (2018) · Journal of International Medical Research · doi:10.1177/0300060518778711 · Cited by 34
Metadata
- Authors
- Kolset, S. O., Reinholt, F. P., & Jenssen, T.
- Venue
- Journal of Histochemistry & Cytochemistry
- Publisher
- SAGE Publications
- Published
- 2012-10-27
- Volume
- 60
- Issue
- 12
- Pages
- 976-986
- ISSN
- 0022-1554 (ISSN-L)
- 1551-5044
- OpenAlex
- W2125326130
- Cited by
- 291
- References
- 84
- FWCI
- 10.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.